On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayJul 27, 2017 9:00 am

Biotech Players Lead the Growth Charge in the Legal Cannabis Market

CannabisNewsWire Editorial Coverage: The backbone of medical advancement is biotechnology, an industry wrought with the incredible potential of novel drug R&D, but vulnerable to the risk of stringent regulatory approval processes. Within this volatile market, however, is the cannabis-biotech sub-sector – a market flourishing with opportunity, innovation, and deep roots of medical possibilities. Fueled by an increasing volume of supportive research, cannabis-based biotech companies are addressing large markets of unmet medical need while rising to meet global demand of epic proportion. Included among several companies in the cannabis-biotech sub-sector is Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (LXRP Profile), a…

Continue Reading

WednesdayJul 26, 2017 9:00 am

Investment Options in the Multi-Billion Dollar Medical Marijuana Industry

CannabisNewsWire Editorial Coverage: Mounting research from around the world suggests marijuana’s potential to treat multiple medical conditions ranging from chronic pain to cancer, epilepsy, HIV/AIDS, anxiety and more.  Predicted to reach $55.8 billion by 2025(1), the global medical marijuana industry presents to investors a wide array of investment opportunities, driven by increasing demand for therapeutic applications of the drug. In turn, funds raised through the public market give marijuana companies the chance to raise capital to build stronger portfolios, increase their market reach and revenue, and offer cannabis-based alternatives to traditional medicine. Companies such as ChineseInvestors.com, Inc. (CIIX) (Profile: CIIX),…

Continue Reading

TuesdayJul 25, 2017 9:00 am

Potential Blockbuster Treatment for Alzheimer’s Disease Stands Out Among Medical Cannabis Companies

CannabisNewsWire Editorial Coverage: Changes in public opinion regarding cannabis have greatly fueled the fire blazing under the red-hot state-legalized marijuana market. A recent Gallup poll shows that 60 percent of Americans now support the legalization of marijuana1, while another report shows that marijuana sales jumped an incredible 30 percent in North America in 2016 to reach $6.7 billion2. While many investors are looking to find profitable plays in this burgeoning market, continuing federal restrictions make medical marijuana one of the safest investment routes. Standout companies that present prime opportunities in this space include India Globalization Capital, Inc. (NYSE MKT: IGC)…

Continue Reading

MondayJul 24, 2017 12:06 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Aims at Future of Cannabinoid Compound Treatment

Specializing in novel cannabinoid drug therapies, InMed Pharmaceuticals is well-poised for cannabinoid research and development of new treatments Glaucoma and skin disease pharmaceuticals now in development have an estimated $7.6 billion potential market InMed Pharmaceutical’s chief medical officer helped $3 billion GW Pharmaceuticals develop one of the first cannabis-based drugs With its proprietary bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline, InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is well-positioned to target the future of cannabinoid pharmaceutical compounds. InMed is a pre-clinical stage biopharmaceutical company specializing in the development of novel therapies through research and development of the…

Continue Reading

ThursdayJul 20, 2017 9:00 am

5 Standout Legal Cannabis Companies Worthy of Consideration

CannabisNewsWire Editorial Coverage: The legal marijuana market continues to gain momentum, driven by increasing public acceptance and an increasing number of investors looking for viable opportunities on a crowded playing field. According to a recent Gallup poll1, 60 percent of Americans now support the legalization of marijuana. As the playing field continues to grow in diversification and size, some of the most recognizable and frequently seen names are ChineseInvestors.com, Inc. (CIIX) (CIIX Profile), Terra Tech Corp. (TRTC), Medical Marijuana, Inc. (MJNA), Marijuana Company of America, Inc. (MCOA) and CV Sciences, Inc. (CVSI). The market presence of ChineseInvestors.com, Inc. (CIIX) is…

Continue Reading

WednesdayJul 19, 2017 9:25 am

ChineseInvestors.com (CIIX) Eyes Expansion in CBD Markets throughout North America

Sees opportunities in the fast-growing international medical marijuana market Plans store opening in San Gabriel, California, with online hemp-based product store already in Shanghai, China, targeting the global Chinese-speaking community Consilium Global Research projects that company revenues will reach $14.8 million by FY2020 ChineseInvestors.com, Inc. (OTCQB: CIIX) is employing a strategy of selling cannabidiol (CBD) in North America. It plans for a brick-and-mortar store in San Gabriel, California, as well as recently incorporating CBD Biotechnology, Inc., in British Columbia, Canada. It also has an online CBD store with hemp-based products located in the free trade zone of Shanghai, China, designed…

Continue Reading

WednesdayJul 19, 2017 9:00 am

Industry Leaders Riding High as Marijuana Demand Outpaces Supply

CannabisNewsWire Editorial Coverage: The legal marijuana market has been growing by leaps and bounds in North America. Sales jumped 30 percent in 2016, accounting for $6.7 billion in retail activity in the United States and Canada. For companies like SinglePoint, Inc. (SING) (SING Profile), which recently formed a joint venture with First Bitcoin Capital Corp. (BITCF), strategic marijuana-centered acquisitions are helping fuel corporate growth while increasing the availability of equipment and packaging and payment solutions for the broader marijuana market. The cannabis industry also benefits from the activities of American Cannabis Company, Inc. (AMMJ), a producer of a proprietary growing…

Continue Reading

TuesdayJul 18, 2017 2:39 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Well-positioned For Expanding Canadian Cannabinoid Market

Lexaria Bioscience Corp. well-positioned for growth in expanding Canadian cannabinoid market Canadian market for cannabis extracts and oils expected to top C$1.6 billion by 2020 Company’s patented technology infuses organically sourced hemp oil into molecules of other substances such as lipids, the basis of the human endocannabinoid system Patented technology enables better-tasting hemp oil-infused gourmet food products with improved bioavailability of cannabinoids Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is well-positioned for growth in the emerging Canadian cannabinoid market. Lexaria is an innovative revenue-generating company developing and out-licensing proprietary technology for delivering bioactive compounds including cannabinoids. With full legalization expected…

Continue Reading

TuesdayJul 18, 2017 2:14 pm

Algae Dynamics Corp. (ADYNF) is Developing Therapies that Offer Safer Delivery of Cannabinoids

Focused on cannabis oil product development Collaborating with Universities of Waterloo & Western Ontario in R&D Strategy to capture market share of non-smoke MMJ products For MMJ patients who don’t want to take up smoking, Algae Dynamics Corp. (OTCQB: ADYNF) is developing non-smoking delivery systems for cannabinoids. The company aims to produce new formulations of algae and cannabis oils that deliver health benefits without the attendant dangers that result from smoking. Smoking is a killer. Statistics published by the Centers for Disease Control and Prevention (CDC) estimate that ‘cigarette smoking kills more than 480,000 Americans each year, with more than…

Continue Reading

ThursdayJul 13, 2017 2:02 pm

India Globalization Capital’s (NYSE: IGC) Cannabis Drug Development for Alzheimer’s Backed by Previous Studies

In the U.S., more than 5.3 million people suffer from Alzheimer’s disease, and 46 million around the world have it Alzheimer’s disease cost the U.S. more than $236 billion in 2016, and the global costs topped $600 billion In 2017, IGC acquired exclusive rights to an Alzheimer’s treatment, based on THC, from the University of South Florida Huge valuation growth potential in light of other Alzheimer’s and cannabis-based companies India Globalization Capital, Inc. (NYSE MKT: IGC) has been working on phytocannabinoid-based therapies for various medical conditions for some time. Its drug development pipeline consists of treatments for seizures, neuropathic pain,…

Continue Reading

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

Contact us: 303.498.7722